These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1075 related articles for article (PubMed ID: 3455745)
1. Slower B16 melanoma growth but greater pulmonary colonization in calorie-restricted mice. Ershler WB; Berman E; Moore AL J Natl Cancer Inst; 1986 Jan; 76(1):81-5. PubMed ID: 3455745 [TBL] [Abstract][Full Text] [Related]
2. The role of intratumor environment in determining spontaneous metastatic activity of a B16 melanoma clone. Alterman AL; Fornabaio DM; Kim YS; Stackpole CW Invasion Metastasis; 1989; 9(4):242-53. PubMed ID: 2737843 [TBL] [Abstract][Full Text] [Related]
3. Hormonal influences on growth of B16 murine melanoma. Simon SR; Ershler WB J Natl Cancer Inst; 1985 May; 74(5):1085-8. PubMed ID: 3858578 [TBL] [Abstract][Full Text] [Related]
4. Generation of phenotypic diversity in the B16 mouse melanoma relative to spontaneous metastasis. Stackpole CW Cancer Res; 1983 Jul; 43(7):3057-65. PubMed ID: 6850615 [TBL] [Abstract][Full Text] [Related]
5. Effect of antiplatelet antibody on the development of pulmonary metastases following injection of CT26 colon adenocarcinoma, Lewis lung carcinoma, and B16 amelanotic melanoma tumor cells into mice. Pearlstein E; Ambrogio C; Karpatkin S Cancer Res; 1984 Sep; 44(9):3884-7. PubMed ID: 6744304 [TBL] [Abstract][Full Text] [Related]
6. Eradication of melanoma pulmonary metastases by immunotherapy with tumor cells engineered to secrete interleukin-2 or gamma interferon. Abdel-Wahab Z; Dar M; Osanto S; Fong T; Vervaert CE; Hester D; Jolly D; Seigler HF Cancer Gene Ther; 1997; 4(1):33-41. PubMed ID: 9012449 [TBL] [Abstract][Full Text] [Related]
7. Effects of the immunomodulator LS 2616 on growth and metastasis of the murine B16-F10 melanoma. Kalland T Cancer Res; 1986 Jun; 46(6):3018-22. PubMed ID: 3486041 [TBL] [Abstract][Full Text] [Related]
8. Metastatic dissemination of B16 melanoma: pattern and sequence of metastasis. Alterman AL; Fornabaio DM; Stackpole CW J Natl Cancer Inst; 1985 Oct; 75(4):691-702. PubMed ID: 3862901 [TBL] [Abstract][Full Text] [Related]
9. Extraction of immunogenic and suppressogenic antigens from variants of B16 melanoma exhibiting low or high metastatic potentials. LeGrue SJ; Hearn DR Cancer Res; 1983 Nov; 43(11):5106-11. PubMed ID: 6616449 [TBL] [Abstract][Full Text] [Related]
11. The use of protein as a carrier of methotrexate for experimental cancer chemotherapy. IV. Therapy of murine melanoma B16 by human serum albumin-methotrexate derivative. Bostík J; Bures L; Spundová M Neoplasma; 1988; 35(3):343-9. PubMed ID: 3405342 [TBL] [Abstract][Full Text] [Related]
12. [Metastatic melanoma B16 of the C57Bl/6J mouse. Biological findings]. Voulot C; Aubert C; Rougé F; Douss T; Santini R C R Seances Soc Biol Fil; 1985; 179(4):445-51. PubMed ID: 2938673 [TBL] [Abstract][Full Text] [Related]
13. Comparison of the metastatic properties of B16 melanoma clones isolated from cultured cell lines, subcutaneous tumors, and individual lung metastases. Poste G; Doll J; Brown AE; Tzeng J; Zeidman I Cancer Res; 1982 Jul; 42(7):2770-8. PubMed ID: 7083167 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of skin tumor promotion by restriction of fat and carbohydrate calories in SENCAR mice. Birt DF; Pinch HJ; Barnett T; Phan A; Dimitroff K Cancer Res; 1993 Jan; 53(1):27-31. PubMed ID: 8416746 [TBL] [Abstract][Full Text] [Related]
15. Phenothiazines induce apoptosis in a B16 mouse melanoma cell line and attenuate in vivo melanoma tumor growth. Gil-Ad I; Shtaif B; Levkovitz Y; Nordenberg J; Taler M; Korov I; Weizman A Oncol Rep; 2006 Jan; 15(1):107-12. PubMed ID: 16328041 [TBL] [Abstract][Full Text] [Related]
16. Suppressing effects of dietary supplementation of the organoselenium 1,4-phenylenebis(methylene)selenocyanate and the Citrus antioxidant auraptene on lung metastasis of melanoma cells in mice. Tanaka T; Kohno H; Murakami M; Kagami S; El-Bayoumy K Cancer Res; 2000 Jul; 60(14):3713-6. PubMed ID: 10919638 [TBL] [Abstract][Full Text] [Related]
17. Antitumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo: successful immunotherapy of established pulmonary metastases from weakly immunogenic and nonimmunogenic murine tumors of three district histological types. Papa MZ; Mulé JJ; Rosenberg SA Cancer Res; 1986 Oct; 46(10):4973-8. PubMed ID: 3489517 [TBL] [Abstract][Full Text] [Related]
18. Xenogeneic DNA immunization in melanoma models for minimal residual disease. Hawkins WG; Gold JS; Blachere NE; Bowne WB; Hoos A; Lewis JJ; Houghton AN J Surg Res; 2002 Feb; 102(2):137-43. PubMed ID: 11796010 [TBL] [Abstract][Full Text] [Related]
19. Growth inhibition of established B16-F10 lung metastases by sequential aerosol delivery of p53 gene and 9-nitrocamptothecin. Gautam A; Waldrep JC; Densmore CL; Koshkina N; Melton S; Roberts L; Gilbert B; Knight V Gene Ther; 2002 Mar; 9(5):353-7. PubMed ID: 11938455 [TBL] [Abstract][Full Text] [Related]
20. Lack of correlation between the progressive growth of spontaneous metastases and their content of infiltrating macrophages. Key M; Talmadge JE; Fidler IJ J Reticuloendothel Soc; 1982 Nov; 32(5):387-96. PubMed ID: 7161769 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]